Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) stock analysis
RXRX · Recursion Pharmaceuticals, Inc. - Class A Common Stock
Latest recorded price: USD 2.72
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 23.3%, free cash flow margin -506.5%, ROIC -86.4%. The model flags 1 risk signal for this company (1 high severity).